Patients would like to contribute to research

03-05-2018

People with diabetes would like to participate in public and commercial research, contributing to the development of new insights into diabetes and health technology. This is one of the results of a new study among the members of the Danish Diabetes Association.

Patients would like to contribute to research
People with diabetes would like to participate in public and commercial research.

73 % of the members who answered the survey, state that they would like to participate in research in the future. Most are interested in answering questionnaires, fewer want to take part in the clinical trials of new medicines. Only half of respondents have participated before, but people generally feel comfortable at the thought of participating in research and development projects and many are interested in learning more about their options.

However, barriers do exist to patient participation. Some of them are patients’ lack of knowledge of enrollment opportunities and lack of feedback from researchers to actual participants in trials.

The study is made by the Danish unit of European Patients Academy EUPATI Denmark, working to increase the capacity and capability of patients to understand and contribute to medicines research and development.

Biopeople and NEXT Partnership have supported the project financially.

Biopeople’s director Per Spindler states: “Through EUPATI Denmark and the national programme “Biomarkers as an emerging growth area”, Biopeople wishes to promote even more collaborative projects, putting the patient and the user at centre stage. This is an example of a study giving us new insights in patient involvement in clinical research. It is one the ways we can get ahead in the development of the life science industry in Denmark.”

The study will also form a point of departure in a debate at Folkemødet – The People's Political Festival 2018 in June, which Biopeople coorganises. The title of the event is “The role of patients in clinical research”.

Biopeople is Denmark’s Life Science Cluster, funded by the Ministry of Higher Education and Science.

Read more:

Article and more information on the study at Danish Diabetes Association’s website (In Danish only)

Event: “The role of patients in clinical research”

Latest news

Patients would like to contribute to research 03-05-2018
People with diabetes would like to participate in public and commercial research, contributing to the development of new insights into diabetes and...
De danske klynger er under lup 27-04-2018
I Life Science nr. 1, 2018 bringer Biopeoples direktør Per Spindlers artikel "De danske klynger under lup", som ser nærmere på sundheds- og life...
Want help to pitch your life science start-up to Silicon Valley investors? Here's how 26-04-2018
Do you have a potential drug candidate that is soon ready for clinical trials? Are you looking for support in internationalisation and funding?...
Overwhelming interest from leading scientists in First Nordic conference on personalized medicine 11-04-2018
The conference in Nyborg looks mainly at the underlying mechanisms causing variability in clinical response and drug toxicity. We talked to organizer...
Cancer therapies: How we link drug sensitivity to molecular profiling to identify biomarkers 23-03-2018
Professor Krister Wennerberg talks on stratified cancer therapies and their predictive biomarkers at the Oncology Network meeting April 9th.

Related

Close
What are you looking for?
This site uses the functionality that older versions of Internet Explorer does not support. You should therefore switch or upgrade your browser.